• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肺 cDC1 驱动慢性阻塞性肺疾病中穿孔素介导的 NK 细胞毒性增加。

Human lung cDC1 drive increased perforin-mediated NK cytotoxicity in chronic obstructive pulmonary disease.

机构信息

Pulmonary & Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Medical School and Michigan Medicine, Ann Arbor, Michigan.

Graduate Program in Immunology, University of Michigan, Ann Arbor, Michigan.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1183-L1193. doi: 10.1152/ajplung.00322.2020. Epub 2021 Oct 27.

DOI:10.1152/ajplung.00322.2020
PMID:34704847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8715029/
Abstract

In chronic obstructive pulmonary disease (COPD), lung natural killer cells (NKs) lyse autologous lung epithelial cells in vitro, but underlying mechanisms and their relationship to epithelial cell apoptosis in vivo are undefined. Although this cytolytic capacity of lung NKs depends on priming by dendritic cells (DCs), whether priming correlates with DC maturation or is limited to a specific DC subset is also unknown. We recruited ever-smokers (≥10 pack-years; = 96) undergoing clinically indicated lung resections. We analyzed lung NKs for cytotoxic molecule transcripts and for cytotoxicity, which we correlated with in situ detection of activated Caspase-3/7+ airway epithelial cells. To investigate DC priming, we measured lung DC expression of CCR2, CCR7, and CX3CR1 and cocultured peripheral blood NKs with autologous lung DCs, either matured using lipopolysaccharide (LPS) (nonobstructed smokers) or separated into conventional dendritic cell type-1 (cDC1) versus cDC type-2 (cDC2) (COPD). Lung NKs in COPD expressed more perforin ( < 0.02) and granzyme B ( < 0.03) transcripts; inhibiting perforin blocked in vitro killing by lung NKs. Cytotoxicity in vitro correlated significantly ( = 0.68, = 0.0043) with numbers of apoptotic epithelial cells per airway. In nonobstructed smokers, LPS-induced maturation enhanced DC-mediated priming of blood NKs, reflected by greater epithelial cell death. Although CCR7 expression was greater in COPD in both cDC1 ( < 0.03) and cDC2 ( = 0.009), only lung cDC1 primed NK killing. Thus, rather than being intrinsic to those with COPD, NK priming is a capacity of human lung DCs that is inducible by recognition of bacterial (and possibly other) danger signals and restricted to the cDC1 subset.

摘要

在慢性阻塞性肺疾病(COPD)中,肺自然杀伤细胞(NK 细胞)在体外裂解自身肺上皮细胞,但潜在机制及其与体内上皮细胞凋亡的关系尚不清楚。虽然肺 NK 细胞的这种细胞溶解能力依赖于树突状细胞(DC)的启动,但启动是否与 DC 成熟相关,还是仅限于特定的 DC 亚群尚不清楚。我们招募了正在接受临床指征性肺切除术的长期吸烟者(≥10 包年;n = 96)。我们分析了肺 NK 细胞的细胞毒性分子转录物和细胞毒性,将其与原位检测到的激活 Caspase-3/7+气道上皮细胞进行了相关性分析。为了研究 DC 启动,我们测量了肺 DC 表达 CCR2、CCR7 和 CX3CR1,并将外周血 NK 细胞与自体肺 DC 共培养,这些 DC 要么使用脂多糖(LPS)成熟(非阻塞性吸烟者),要么分离为传统树突状细胞 1 型(cDC1)和 cDC2(COPD)。COPD 患者的肺 NK 细胞表达更多的穿孔素(<0.02)和颗粒酶 B(<0.03)转录物;抑制穿孔素可阻断肺 NK 细胞的体外杀伤。体外细胞毒性与每个气道的凋亡上皮细胞数量显著相关(r = 0.68,p = 0.0043)。在非阻塞性吸烟者中,LPS 诱导的成熟增强了 DC 介导的血液 NK 细胞的启动,这反映在更大的上皮细胞死亡上。尽管 CCR7 在 COPD 患者的 cDC1(<0.03)和 cDC2(p = 0.009)中表达更高,但只有肺 cDC1 可启动 NK 细胞的杀伤作用。因此,NK 细胞的启动不是 COPD 患者所特有的,而是人类肺 DC 的一种能力,这种能力可通过识别细菌(和可能其他)危险信号而被诱导,并仅限于 cDC1 亚群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/a3eca19e50fd/ajplung.00322.2020_f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/7a8ebc8809f7/ajplung.00322.2020_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/88dddff4c336/ajplung.00322.2020_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/78f9290a1612/ajplung.00322.2020_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/703b0db08617/ajplung.00322.2020_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/bd59919458f5/ajplung.00322.2020_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/181d03498850/ajplung.00322.2020_f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/db65c8fb5310/ajplung.00322.2020_f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/a3eca19e50fd/ajplung.00322.2020_f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/7a8ebc8809f7/ajplung.00322.2020_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/88dddff4c336/ajplung.00322.2020_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/78f9290a1612/ajplung.00322.2020_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/703b0db08617/ajplung.00322.2020_f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/bd59919458f5/ajplung.00322.2020_f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/181d03498850/ajplung.00322.2020_f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/db65c8fb5310/ajplung.00322.2020_f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64b5/8715029/a3eca19e50fd/ajplung.00322.2020_f008.jpg

相似文献

1
Human lung cDC1 drive increased perforin-mediated NK cytotoxicity in chronic obstructive pulmonary disease.人肺 cDC1 驱动慢性阻塞性肺疾病中穿孔素介导的 NK 细胞毒性增加。
Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1183-L1193. doi: 10.1152/ajplung.00322.2020. Epub 2021 Oct 27.
2
Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.肺树突状细胞通过 IL-15Rα 驱动慢性阻塞性肺疾病中的自然杀伤细胞细胞毒性。
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1140-1150. doi: 10.1164/rccm.201712-2513OC.
3
Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.慢性阻塞性肺疾病气道中与 CD94(Kp43)减少相关的自然杀伤细胞和自然杀伤 T 样细胞的增强细胞毒性功能。
Respirology. 2013 Feb;18(2):369-76. doi: 10.1111/j.1440-1843.2012.02287.x.
4
Increased airway granzyme b and perforin in current and ex-smoking COPD subjects.当前吸烟者和既往吸烟者慢性阻塞性肺疾病患者气道颗粒酶B和穿孔素增加。
COPD. 2006 Dec;3(4):179-87. doi: 10.1080/15412550600976868.
5
Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.树突状细胞增强人脐带血CD34+细胞来源的自然杀伤细胞的细胞毒性
J Immunol. 2001 Feb 1;166(3):1590-600. doi: 10.4049/jimmunol.166.3.1590.
6
Altered effector function of peripheral cytotoxic cells in COPD.慢性阻塞性肺疾病(COPD)中外周细胞毒性细胞效应功能的改变
Respir Res. 2009 Jun 22;10(1):53. doi: 10.1186/1465-9921-10-53.
7
Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease.CD8/CD28(null)T 细胞和替代共刺激分子在慢性阻塞性肺疾病中的作用。
Clin Exp Immunol. 2011 Oct;166(1):94-102. doi: 10.1111/j.1365-2249.2011.04455.x.
8
Cigarette smoke affects dendritic cell maturation in the small airways of patients with chronic obstructive pulmonary disease.香烟烟雾会影响慢性阻塞性肺疾病患者小气道中树突状细胞的成熟。
Mol Med Rep. 2015 Jan;11(1):219-25. doi: 10.3892/mmr.2014.2759. Epub 2014 Oct 23.
9
Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.COPD 患者诱导痰中细胞毒性细胞的效应功能增强。
Respir Res. 2010 Jun 11;11(1):76. doi: 10.1186/1465-9921-11-76.
10
Systemic hypoxia affects exercise-mediated antitumor cytotoxicity of natural killer cells.系统性缺氧会影响自然杀伤细胞介导的运动抗肿瘤细胞毒性。
J Appl Physiol (1985). 2009 Dec;107(6):1817-24. doi: 10.1152/japplphysiol.00687.2009. Epub 2009 Sep 17.

引用本文的文献

1
Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-β1 in type 1 conventional dendritic cells.同种异体移植耐受诱导过程中的调节性T细胞激活需要1型传统树突状细胞中线粒体诱导的转化生长因子-β1。
J Clin Invest. 2025 Jul 10;135(18). doi: 10.1172/JCI178960. eCollection 2025 Sep 16.
2
Exploring the pathogenesis and clinical implications of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO): a narrative review.探索哮喘、慢性阻塞性肺疾病(COPD)及哮喘-慢性阻塞性肺疾病重叠综合征(ACO)的发病机制及临床意义:一项叙述性综述
Front Med (Lausanne). 2025 Apr 17;12:1514846. doi: 10.3389/fmed.2025.1514846. eCollection 2025.
3

本文引用的文献

1
Why new biology must be uncovered to advance therapeutic strategies for chronic obstructive pulmonary disease.为推进慢性阻塞性肺疾病的治疗策略,必须揭示新的生物学机制。
Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L1-L11. doi: 10.1152/ajplung.00367.2020. Epub 2020 Nov 11.
2
Human Lung Conventional Dendritic Cells Orchestrate Lymphoid Neogenesis during Chronic Obstructive Pulmonary Disease.人类肺常规树突状细胞在慢性阻塞性肺疾病期间协调淋巴组织生成。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):535-548. doi: 10.1164/rccm.201906-1123OC.
3
Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity.
Decoding the causal association between immune cells and three chronic respiratory diseases: Insights from a bi-directional Mendelian randomization study.
解码免疫细胞与三种慢性呼吸道疾病之间的因果关联:双向孟德尔随机化研究的见解
BMC Pulm Med. 2025 Apr 15;25(1):183. doi: 10.1186/s12890-025-03641-w.
4
Clinical value of CD3CD56 natural killer cells, IL-2, and IL-8 in acute exacerbation of chronic obstructive pulmonary disease in patients with respiratory failure.CD3CD56自然杀伤细胞、白细胞介素-2和白细胞介素-8在慢性阻塞性肺疾病急性加重期合并呼吸衰竭患者中的临床价值
Am J Transl Res. 2024 Nov 15;16(11):6477-6488. doi: 10.62347/TYUO6357. eCollection 2024.
5
A model of dysregulated crosstalk between dendritic, natural killer, and regulatory T cells in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中树突状细胞、自然杀伤细胞和调节性 T 细胞之间失调串扰的模型。
Trends Immunol. 2024 Jun;45(6):428-441. doi: 10.1016/j.it.2024.04.010. Epub 2024 May 18.
6
The paradox of the safer cigarette: understanding the pulmonary effects of electronic cigarettes.更安全香烟的悖论:理解电子烟对肺部的影响
Eur Respir J. 2024 Jun 28;63(6). doi: 10.1183/13993003.01494-2023. Print 2024 Jun.
7
Concise review: The heterogenous roles of BATF3 in cancer oncogenesis and dendritic cells and T cells differentiation and function considering the importance of BATF3-dependent dendritic cells.简明回顾:考虑到依赖 BATF3 的树突状细胞的重要性,BATF3 在癌症发生和树突状细胞与 T 细胞分化和功能中的异质作用。
Immunogenetics. 2024 Apr;76(2):75-91. doi: 10.1007/s00251-024-01335-x. Epub 2024 Feb 15.
8
Endothelial Regulates Expression of Pulmonary Lymphatic Junctional and Inflammation Genes in Mouse Lungs Impacting Lymphatic Transport.内皮细胞调节小鼠肺中影响淋巴运输的肺淋巴连接和炎症基因的表达。
Res Sq. 2024 Jan 24:rs.3.rs-3808970. doi: 10.21203/rs.3.rs-3808970/v1.
9
MICa/b-dependent activation of natural killer cells by CD64 inflammatory type 2 dendritic cells contributes to autoimmunity.CD64 炎性 2 型树突状细胞通过 MICa/b 依赖性激活自然杀伤细胞导致自身免疫。
EMBO J. 2023 Dec 1;42(23):e113714. doi: 10.15252/embj.2023113714. Epub 2023 Nov 2.
10
Periodontopathogens and and Their Roles in the Progression of Respiratory Diseases.牙周病原体及其在呼吸系统疾病进展中的作用。 需注意,原文中“and”重复使用,可能存在错误表述。
Pathogens. 2023 Aug 30;12(9):1110. doi: 10.3390/pathogens12091110.
转录基础上的小鼠和人类树突状细胞异质性。
Cell. 2019 Oct 31;179(4):846-863.e24. doi: 10.1016/j.cell.2019.09.035. Epub 2019 Oct 24.
4
Damage-Associated Molecular Patterns and Myeloid-Derived Suppressor Cells in Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease Patients.慢性阻塞性肺疾病患者支气管肺泡灌洗液中的损伤相关分子模式和髓系来源的抑制细胞。
J Immunol Res. 2019 Jul 2;2019:9708769. doi: 10.1155/2019/9708769. eCollection 2019.
5
Natural Killer Cells in the Lungs.肺部自然杀伤细胞。
Front Immunol. 2019 Jun 25;10:1416. doi: 10.3389/fimmu.2019.01416. eCollection 2019.
6
NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing.NK 细胞在连续杀伤过程中从颗粒酶 B 切换到死亡受体介导的细胞毒性。
J Exp Med. 2019 Sep 2;216(9):2113-2127. doi: 10.1084/jem.20181454. Epub 2019 Jul 3.
7
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
8
B Cells Caught in the Act: Class Switching to IgA in Lung Lymphoid Follicles in Chronic Obstructive Pulmonary Disease.B细胞当场被抓:慢性阻塞性肺疾病患者肺淋巴滤泡中向IgA的类别转换
Am J Respir Crit Care Med. 2019 Mar 1;199(5):548-550. doi: 10.1164/rccm.201810-1907ED.
9
Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study.轻度和中度慢性阻塞性肺疾病中的小气道疾病:一项横断面研究。
Lancet Respir Med. 2018 Aug;6(8):591-602. doi: 10.1016/S2213-2600(18)30196-6. Epub 2018 Jul 4.
10
Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.肺树突状细胞通过 IL-15Rα 驱动慢性阻塞性肺疾病中的自然杀伤细胞细胞毒性。
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1140-1150. doi: 10.1164/rccm.201712-2513OC.